SCM

Squadron Capital Management Portfolio holdings

AUM $224M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1 +$22.4M
2 +$21.9M
3 +$16.8M
4
ABVX
Abivax
ABVX
+$15.8M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$9.27M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLMD icon
1
Relmada Therapeutics
RLMD
$320M
$32.4M 14.44%
+6,700,000
COGT icon
2
Cogent Biosciences
COGT
$5.86B
$27.7M 12.36%
+780,000
MAZE
3
Maze Therapeutics
MAZE
$2.18B
$20.3M 9.06%
+490,000
ABVX
4
Abivax
ABVX
$10.1B
$19.6M 8.73%
+145,000
KALV icon
5
KalVista Pharmaceuticals
KALV
$786M
$11.3M 5.04%
+700,000
PALI icon
6
Palisade Bio
PALI
$258M
$10.6M 4.72%
+4,500,000
EWTX icon
7
Edgewise Therapeutics
EWTX
$3.2B
$8.69M 3.88%
+350,000
IKT icon
8
Inhibikase Therapeutics
IKT
$235M
$8.66M 3.87%
+4,225,000
KOD icon
9
Kodiak Sciences
KOD
$1.7B
$8.16M 3.64%
+291,710
TERN icon
10
Terns Pharmaceuticals
TERN
$4.41B
$7.68M 3.43%
+190,000
TARS icon
11
Tarsus Pharmaceuticals
TARS
$3.18B
$6.55M 2.92%
+80,000
UPB
12
Upstream Bio Inc
UPB
$439M
$6.26M 2.79%
+230,650
SPRB
13
Spruce Biosciences
SPRB
$63.1M
$6.1M 2.72%
+70,000
XENE icon
14
Xenon Pharmaceuticals
XENE
$3.36B
$4.73M 2.11%
+105,551
DBVT
15
DBV Technologies
DBVT
$1.21B
$4.6M 2.05%
+240,000
HELP
16
Cybin Inc
HELP
$348M
$4.29M 1.92%
+525,000
LPCN icon
17
Lipocine
LPCN
$54.9M
$4.26M 1.9%
+530,000
BLTE
18
Belite Bio
BLTE
$7.13B
$4.16M 1.86%
+26,000
GHRS icon
19
GH Research
GHRS
$948M
$4M 1.79%
+315,000
EPRX
20
Eupraxia Pharmaceuticals
EPRX
$414M
$3.77M 1.68%
+500,000
VTYX icon
21
Ventyx Biosciences
VTYX
$1B
$3.7M 1.65%
+410,000
NXTC icon
22
NextCure
NXTC
$46.1M
$3.36M 1.5%
+236,966
WVE icon
23
Wave Life Sciences
WVE
$2.56B
$2.98M 1.33%
+175,000
KTTA icon
24
Pasithea Therapeutics
KTTA
$19.1M
$2.71M 1.21%
+2,100,000
CMPS
25
Compass Pathways
CMPS
$734M
$2.68M 1.2%
+388,287